Health
Australia signs agreement for new Covid-19 drug – Pharmaceutical Business Review
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths…
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths and hospitalisations due to Covid-19.
Being trialled in the US, this drug is yet to gain approval from the regulatory authorities.
…
Continue Reading